Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$107K Buy
2,303
+203
+10% +$9.39K 0.01% 461
2026
Q1
$103K Buy
2,100
+508
+32% +$23.6K 0.01% 450
2025
Q4
$69.4K Buy
1,592
+11
+0.7% +$502 0.01% 499
2025
Q3
$71.2K Buy
1,581
+159
+11% +$6.98K 0.01% 487
2025
Q2
$61.7K Sell
1,422
-122
-8% -$5.43K 0.01% 509
2025
Q1
$71.1K Sell
1,544
-107
-6% -$4.47K 0.01% 449
2024
Q4
$62.1K Buy
1,651
+382
+30% +$14.8K 0.01% 478
2024
Q3
$51.5K Buy
1,269
+125
+11% +$4.7K 0.01% 505
2024
Q2
$39.6K Sell
1,144
-260
-19% -$9.6K 0.01% 535
2024
Q1
$52.7K Buy
1,404
+24
+2% +$858 0.01% 483
2023
Q4
$49.5K Buy
+1,380
New +$53.2K 0.01% 479
2023
Q3
Sell
-1,721
Closed -$70.1K 474
2023
Q2
$70.1K Sell
1,721
-401
-19% -$16.6K 0.01% 371
2023
Q1
$88.9K Buy
2,122
+862
+68% +$35.9K 0.02% 329
2022
Q4
$54.5K Sell
1,260
-325
-21% -$12.8K 0.01% 396
2022
Q3
$59K Hold
1,585
0.02% 325
2022
Q2
$72K Buy
1,585
+500
+46% +$23.5K 0.02% 291
2022
Q1
$52K Sell
1,085
-387
-26% -$16.4K 0.01% 389
2021
Q4
$61K Buy
+1,472
New +$55.4K 0.02% 322
2021
Q3
Sell
-806
Closed -$25K 523
2021
Q2
$25K Hold
806
0.01% 482
2021
Q1
$25K Buy
+806
New +$24.2K 0.01% 365

Other funds holding EXC

CVA Family Office's EXC Position: Q2 2026 in Review

CVA Family Office increased its Exelon (EXC) stake by 9.7% in Q2 2026, buying an estimated $9.39K and bringing the position to 2,303 shares worth $107K. The position accounts for 0.01% of the portfolio, ranked #461.

CVA Family Office first reported a position in EXC in Q1 2021 and has held it in 20 quarters since. 1,287 funds tracked by Wall St. Rank hold EXC as of Q2 2026.

  • CVA Family Office held 2,303 shares of Exelon worth $107K as of Q2 2026.
  • CVA Family Office bought 203 Exelon shares in Q2 2026, an estimated $9.39K.
  • Exelon made up 0.01% of CVA Family Office's portfolio in Q2 2026, its #461 holding.
  • CVA Family Office first reported a position in Exelon in Q1 2021 and has held it in 20 quarters since.
  • 1,287 funds tracked by Wall St. Rank held Exelon as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.